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Inappropriate Activation of the TSC/Rheb/mTOR/S6K
Cassette Induces IRS1/2 Depletion,
Insulin Resistance, and Cell Survival Deficiencies
cient cells after a 24 hr treatment with the mTOR inhibi-
tor, rapamycin. The insulin-stimulated in vitro kinase
activity of Akt is also similar to wild-type levels in TSC
null cells treated with rapamycin (Figure 1B).
If in TSC1 and TSC2 null cells, IRS depletion underlies
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the Akt activation deficiency, then growth factor path-
ways dependent upon IRS1/2 should display subnormal
Akt activation similar to the insulin pathway, whereasSummary
IRS-independent pathways should remain relatively un-
affected. Indeed, Akt activation in response to IGF-ITuberous sclerosis is a largely benign tumor syndrome
(insulin-like growth factor-I ), a pathway in which IRSderived from the acquisition of somatic lesions in
proteins are obligatory, is also undetectable in TSC-genes encoding the tumor suppressor products, TSC1
deficient cells (Figures 1C and S1A in the Supplementalor TSC2. Loss of function of the TSC1-TSC2 complex,
Data available with this article online). In contrast, PDGFwhich acts as a Rheb GAP, yields constitutive, unre-
(platelet-derived growth factor) treatment, which acti-strained signaling from the cell growth machinery
vates PI3K (phosphatidylinositol 3-kinase) indepen-comprised of Rheb, mTOR, and S6K. We demonstrate
dently of IRS1/2, induced Akt activation (Figure 1C).herein that constitutive activation of the Rheb/mTOR/
However, the extent of Akt activation was reduced inS6K cassette, whether by genetic deletion of TSC1 or
TSC1 and TSC2 null cells compared to wild-type cellsTSC2 or by ectopic expression of Rheb, is sufficient
(Figure S1B), presumably due to reduced expression ofto induce insulin resistance. This is the result of
the PDGFR in these cells [4]. In TSC-deficient cells,downregulation of the insulin receptor substrates,
rapamycin treatment for 24 hr increased Akt activationIRS1 and IRS2, which become limiting for signal trans-
in response to both insulin and IGF-I to similar extents,mission from the insulin receptor to PI3K. Downstream
whereas rapamycin did not enhance the ability of PDGFof PI3K, the survival kinase, Akt, is completely refrac-
to activate Akt (Figure 1C).tory to activation by IRS-dependent growth factor
In the TSC-deficient state, IRS depletion becomespathways such as insulin or IGF-I in TSC1- or TSC2-
critical only if IRS1 and IRS2 are reduced to limitingdeficient cells but not to activation by IRS-independent
levels, effectively uncoupling the activated InsR frompathways such as those utilized by PDGF. The antiapo-
PI3K. Analysis of immunoprecipitates from TSC1 andptotic program induced by IGF-I but not PDGF is se-
TSC2 null cells reveals a drastic reduction in p85-asso-verely compromised in TSC2 null cells. Our results
ciated IRS1, IRS2, and InsR compared to wild-typesuggest that inappropriate activation of the Rheb/
immunoprecipitates (Figure 1D). Moreover, tyrosinemTOR/S6K pathway imposes a negative feedback
phosphorylation within the 150–180 kDa size range isprogram to attenuate IRS-dependent processes such
conspicuously absent, reflecting the absence of IRS1as cell survival.
and IRS2 in these complexes (Figure 1D). Tyrosine phos-
phorylation of InsR is normal in TSC-deficient cells
Results and Discussion (data not shown).
To eliminate the possibility that the lack of IRS1 and
The turnover of IRS1 and IRS2 (insulin receptor sub- IRS2 could arise from random genetic alterations fre-
strates 1 and 2 ) is a physiological mechanism to at- quently observed as MEFs are propagated in culture, we
tenuate insulin signaling during prolonged exposure to infected TSC2 null MEFs with wild-type, human TSC2-
insulin. This process is mTOR (mammalian target of ra- expressing retrovirus and selected two clonal lines sta-
pamycin)-dependent, as rapamycin prevents IRS1 and/ bly expressing TSC2 at levels similar to wild-type MEFs.
or IRS2 turnover in multiple cell types treated chronically TSC2 reconstitution of TSC2 null cells restored endoge-
with insulin [1–3]. We therefore assayed the steady-state nous levels of both IRS1 and IRS2 in addition to the
abundance of IRS1 and IRS2 in TSC1 and TSC2 (tuber- magnitude and kinetics of Akt activation by insulin (Fig-
ous sclerosis complex 1 and 2 ) null MEFs (mouse em- ure 1E). Furthermore, the basal and insulin-stimulated
bryo fibroblasts), which exhibit consititutively elevated activation profiles of four effectors of mTOR, S6K1, rpS6,
mTOR signaling. IRS1, and to lesser extent IRS2, levels eIF4G, and 4EBP1 were similar between wild-type cells
were reduced in TSC1- and TSC2-deficient MEFs (Fig- and TSC2 null cells reconstituted with TSC2. These ef-
ure 1A), suggesting that IRS1/2 expression is promoted fectors showed constitutively high basal phosphoryla-
by the TSC1-TSC2 complex. Concordantly, the insulin- tion in TSC2 null cells as expected if mTOR signaling
induced phosphorylation of Ser473, the Akt hydropho- was unrestrained. Thus, reintroduction of TSC2 into the
bic motif, is undetectable in TSC1 and TSC2 null MEFs, TSC2-deficient background returns the cell to a bio-
although the expression of Akt is unaltered (Figure 1A). chemical state indistinguishable from wild-type.
IRS1/2 expression and phosphorylation of Ser473 are Extended insulin exposure has been shown to induce
concomitantly rescued to wild-type levels in TSC-defi- proteasomal destruction of IRS proteins [1, 5]. To deter-
mine whether or not the rate of turnover of IRS1/2 is
increased as a consequence of TSC deficiency, we mea-*Correspondence: hunter@salk.edu
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Figure 1. Genetic TSC Deficiency Causes Insulin Resistance
(A) MEFs were cultured in DMEM/0.4% FCS (fetal calf serum) in the presence or absence of 100 nM rapamycin for 24 hr and then stimulated
with 200 nM insulin for 5 min. Immunoblot analysis of whole-cell lysates are shown.
(B) MEFs were treated as in (A) followed by immunoprecipitation of Akt. The activity of Akt was determined by in vitro kinase assay using the
Akt substrate peptide, RPRAATF. The data presented are means  standard error for three determinations and are representative of three
independent trials.
(C) MEFs were cultured in DMEM/0.4% FCS in the presence or absence of 100 nM rapamycin for 24 hr prior to stimulation with 200 nM insulin,
100 ng/ml IGF-I, or 100 ng/ml PDGF for 5 min. Immunoblot analysis of cell extracts is shown.
(D) Cells were cultured in DMEM/0.4% FCS overnight prior to stimulation with 200 nM insulin for 5 min. The regulatory subunit (p85) of PI3K
was immunoprecipitated and immune complexes analyzed by immunoblotting with the indicated antibodies.
(E) TSC2 null MEFs were infected with TSC2-encoding retrovirus, and infected cells were selected with puromycin. Two clonal lines stably
reexpressing TSC2 at levels similar to wild-type MEFs were isolated and designated TSC2/ (R2) and TSC2/ (R4). Cells were cultured in
DMEM/0.4% FCS overnight, then stimulated with 200 nM insulin for the indicated times. Immunoblot analysis of whole-cell extracts is shown.
sured the decay rate of IRS proteins in the absence of TSC null cells, indicating that mTOR drives IRS protein
turnover in these cells. The IRS1 and IRS2 proteins wereprotein synthesis and asked whether IRS1 and IRS2
protein could be stabilized by inhibition of mTOR. Cells inherently less stable in the absence of TSC1 or TSC2
(Figure 2). IRS1 and IRS2 mRNA levels were also re-were pretreated with rapamycin for 24 hr and then cul-
tured in the presence of the protein synthesis inhibitor, duced in TSC-deficient cells (Figures S2A and S2B),
an effect not due, however, to altered mRNA stabilitycycloheximide, for a subsequent 24 hr period over which
IRS1/2 protein decay was monitored. The slow decay (Figures S2C and S2D). Moreover, IRS1/2 mRNA is re-
stored to near-wild-type levels following 24 hr treatmentrate of IRS1 and IRS2 was unaffected by rapamycin
treatment in wild-type cells (Figures 2C and 2F). In con- with mTOR inhibitors (Figure S2B). Thus, in the absence
of TSC1/2, IRS downregulation is the cumulative effecttrast, rapamycin reduced the decay rates of IRS1/2 in
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Figure 2. The Degradation of IRS1 and IRS2 Protein Is Accelerated in TSC-Deficient Cells
Cells were cultured in DMEM/10% FCS in the presence or absence of 100 nM rapamycin for 24 hr, then treated with 1 M cycloheximide for
an additional 24 hr. The rate of decay of IRS1 (A–C) or IRS2 (D–F) was monitored by immunoblot analysis and quantified using an Odyssey
infrared detection system (Licor). The data are the means  standard error of three independent experiments.
of reduced mRNA transcription and accelerated protein pathway observed in TSC1 and TSC2 null MEFs is reca-
pitulated in HEK293 cells overexpressing wild-typedegradation.
Perturbation of the TSC1-TSC2 complex, either by Rheb.
Similar to TSC1 and TSC2 null cells, the activation ofgenetic ablation or by the acquisition of specific disrup-
tive mutations, inhibits the GAP activity of TSC2 toward Akt by insulin in HEK293 cells expressing Rheb is se-
verely compromised. When Myc-tagged Rheb and HA-Rheb (Ras homolog enriched in brain) [6, 7]. Conse-
quently, Rheb accumulates in the active, GTP bound tagged Akt are coexpressed, the insulin-induced phos-
phorylation of Akt on Ser473 and the T loop site, Thr308,form and, thus, signals constitutively and unabatedly to
mTOR and S6K (ribosomal protein S6 kinase). Moreover, is reduced (Figure 3B). In light of the functional conser-
vation between cell types and due to the ease and effi-owing to relatively limiting intracellular Rheb GAP activ-
ity, overexpression of wild-type Rheb leads to a marked ciency with which HEK293 cells can be transfected, this
system was suited to dissect the genetic interactions link-increase in GTP loading and, hence, activation of exoge-
nous Rheb [8]. Therefore, cells expressing ectopic Rheb ing Rheb activation to the apparent insulin resistance.
Expression of Myc-tagged Rheb with HA-tagged Aktin many ways phenocopy TSC deficiency. Because
depletion of IRS levels is a response common to defi- resulted in the complete abrogation of insulin-induced
Akt kinase activity detected in HA immunoprecipitatesciency of either TSC1 or TSC2, we tested whether ex-
pression of Rheb was also sufficient to reduce IRS lev- (Figure 3C). Furthermore, whereas the Rheb effector
domain mutant, Ile39Lys-Rheb, shows compromised in-els. As indicated by GFP expression, HEK293 cells are
transfected at 80–90% efficiency under the conditions hibition of Akt, a Rheb mutant with 2- to 3-fold higher
activity than wild-type, Gln64Leu-Rheb [7], inhibits Aktused in this study (data not shown). Ectopically ex-
pressed Rheb reduced the expression of endogenous as well as wild-type Rheb (Figure 3C). Akt phosphoryla-
tion of Thr308 and Ser473 paralleled kinase activity mea-IRS1 and IRS2 in a dose-dependent manner 72 hr post-
transfection (Figure 3A), suggesting that the biological surements in these experiments (Figure 3C). The effects
of wild-type and Gln64Leu-Rheb on phosphorylation ofresponse of constitutive signaling through the mTOR
TSC1-TSC2 Complex Regulates Insulin Sensitivity
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Figure 3. Rheb Reduces IRS1/2 Expression and Represses Akt Activation through mTOR and S6K1
(A) HEK293 cells were transfected with incremental doses of plasmid encoding Myc-Rheb as indicated. 72 hr post-transfection, the expression
of endogenous IRS1/2 was monitored by immunoblot analysis of whole-cell extracts.
(B) HEK293 cells were transfected with HA-Akt in the presence or absence of Myc-Rheb. 24 hr post-transfection cells were switched to serum-
free DMEM and cultured for an additional 48 hr prior to stimulation with 200 nM insulin for 5 min. HA-Akt was immunoprecipitated with anti-
HA (12CA5) antibody from whole-cell lysates and subjected to immunoblotting.
(C) Cells were cultured and transfected as in (B) with either of the following Myc-Rheb constructs: wild-type (WT), Ile39Lys (I39K), or Gln64Leu
(Q64L). Akt activity was determined by immunoprecipitation of HA-Akt followed by in vitro kinase assay. Data are the means of duplicate
measurements and are representative of three independent trials. Representative immunoblots are shown.
(D) HEK293 cells were cotransfected with Myc-Rheb, HA-Akt with or without wild-type, or kinase-deficient (KD) mTOR. Akt activity was
determined in HA immunoprecipitates. Data are the means of duplicate measurements and are representative of three independent trials.
Representative immunoblots are shown.
(E) 6Myc-Akt was coexpressed with Myc-Rheb, kinase-deficient HA-S6K1, or wild-type HA-Raptor. Akt activity was determined following
Myc immunoprecipitation. Data are the means of duplicate measurements and are representative of three independent trials. Representative
immunoblot analysis of this experiment is displayed.
(F) HA-Akt and Myc-Rheb were transfected with IRS1 or activated, IRS-independent PI3K (Myc-p110*). HA-Akt was immunoprecipitated and
assayed for Akt kinase activity. Representative immunoblot analysis of the experiment is presented.
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Figure 4. TSC-Deficient Cells Exhibit Compromised Cell Survival
(A) TSC2/ MEFs or a pooled population of TSC2/(R2) and –(R4) (designated TSC2/[R]) were first placed in serum-free medium to
eliminate all growth factors from the medium. Then the indicated growth factors or 10% FCS was added for 6 hr. Immunoblot analysis was
carried out on whole-cell lysates (left panel). Alternatively, cells were cultured in medium containing 0.4% FCS overnight, then stimulated for
4 hr with 100 ng/ml IGF-I. Cells were then cultured in the presence of 5 g/ml camptothecin (CMPT) for an additional 24 hr. Immunoblot
analysis is shown (right panel).
(B) Cells were cultured in the presence or absence of 100 nM rapamycin for 24 hr prior to the addition of CMPT or etoposide (ETOP) for an
additional 24 hr. Cells were fixed with 70% ethanol, stained with propidium iodide, and subjected to FACS to resolve sub-G1 (apoptotic)
populations (designated by arrows).
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coexpressed S6K1 and endogenous 4EBP1 are equiva- shown by FACS (Figure 4B). Furthermore, rapamycin
protected TSC1 and TSC2 null cells but not wild-typelent to or greater than, respectively, insulin-stimulated
cells expressing vector alone (Figure S3 and [7]). In con- cells from CMPT- and ETOP-induced cell death. This
observation is consistent with TSC deficiency fosteringtrast, Ile39Lys-Rheb caused little increase in phosphory-
lation of these mTOR substrates (Figure S3). a “dependence” on mTOR signaling, rendering cells ex-
quisitely sensitive to rapamycin. Both the TSC2/ andThe failure of Rheb to inhibit Akt in HEK293 cells ex-
pressing catalytically dead mTOR but not wild-type wild-type cells used are p53-deficient, whereas the
TSC1/ cells are not (Figure S4). Thus, the sensitivitymTOR demonstrates that mTOR participates in this pro-
cess downstream of Rheb (Figure 3D). Expression of to CMPT and ETOP can be dissociated from loss of p53
and is specific to TSC deficiency.the mTOR binding partner, Raptor, has been shown to
inhibit the kinase activity of mTOR and modestly reduce Our findings demonstrate that in TSC-deficient cells,
mTOR signaling constitutively engages a negative feed-S6K1 phosphorylation [9]. Nevertheless, expression of
Raptor failed to influence Rheb inhibition of Akt (Figure back mechanism to regulate IRS1/2 expression, which
in normal cells, is engaged by insulin or IGF-I hypersuffi-3E). Because insulin activates S6K1 independently of
the mTOR-Raptor interaction [9], Raptor’s modulation ciency (Figure 4C). In Drosophila larvae, deletion of
dTSC1 inhibits Akt activity, which can be rescued byof mTOR may be restricted to nutrient regulation and
therefore may not affect the ability of Rheb to repress codeletion of dS6K [10]. Ser473 phosphorylation of Akt
is also repressed in TSC2/ MEFs stimulated withinsulin-induced Akt activity. Kinase-deficient S6K1,
however, mitigated the Rheb-induced Akt inhibition to insulin [11]. Our findings are consistent with S6K1 (and
perhaps other S6Ks) providing an essential function inan extent similar to loss-of-function Rheb and kinase-
dead mTOR (Figure 3E). Wild-type S6K1 does not affect IRS1/2 depletion downstream of TSC1-2, Rheb, and
mTOR. Consistent with this postulation, S6Ks can alsothe ability of Rheb to inhibit Akt (data not shown). Collec-
tively, these data indicate that the intact Rheb/mTOR/ inhibit the ability of IRS1 to signal to PI3K, in part,
through direct phosphorylation [12].S6K pathway is required for Rheb to inhibit Akt.
Constitutive signaling through Rheb, either secondary We have observed that stable 70–80% depletion of
TSC2 by siRNA in HEK293 cells only marginally affectsto genetic TSC deficiency or by overexpression of Rheb
itself, mimics the insulin-resistant condition evoked by S6K or Akt activation or IRS1/2 abundance (data not
shown), indicating that little TSC2 is necessary to re-chronic hyperinsulinemia through constitutive feedback
regulation of IRS1/2. Coexpression of either IRS1 or an strain mTOR signaling in some cell contexts. Therefore,
TSC1 or TSC2 haploinsufficiency, as is manifest in indi-IRS-independent, active allele of the catalytic subunit
of PI3K (p110*) dramatically enhances the activation of viduals with tuberous sclerosis, may not give rise to
generalized diabetes. Rather, insulin resistance may beAkt in cells overexpressing Rheb (Figure 3F). Thus, by
forcing the expression of IRS1 or PI3K ectopically, the restricted to specific lesions having undergone loss of
heterozygosity at either TSC locus. We suggest that thenegative feedback regulation of IRS signaling is by-
passed, as is the dependence of insulin on endogenous intrinsic insulin/IGF-I resistance of these lesions could
be exploited with tailored interventions, such as chemo-IRS1/2 to signal Akt activation.
Because IRS1/2 and Akt support IGF-I-mediated cell therapy, to manage the disorder.
survival, we assayed the comparative ability of growth
Supplemental Datafactors to engage survival responses in TSC2/ and
Supplemental Data including Experimental Procedures and four ad-TSC2/ MEFs reconstituted with TSC2 (TSC2/[R]).
ditional figures are available at http://www.current-biology.com/cgi/The absence of growth factors induced the cleaved,
content/full/14/18/1650/DC1/.
active form of Caspase 3, a marker of apoptosis in both
cell lines (Figure 4A, left panel). In TSC2/ but not
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Note Added in Proof
In the IEP (immediate early publication) version of this paper pub-
lished online August 12, 2004, reference [12] was cited as personal
communication but had been published online July 12, 2004.
